BioLife Solutions, Inc. (BioLife), incorporated on March 25, 1998, is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage, and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products.
The Company markets its HypoThermosol FRS and CryoStor biopreservation media products to regenerative medicine, biobanking, drug discovery markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers and suppliers of cells to the drug discovery, toxicology testing and diagnostic markets, including private and public cell therapy companies. The Company's subsidiary, biologistex CCM, LLC (biologistex CCM), is engaged in acquiring, developing, maintaining, owning, operating, marketing and selling an integrated platform of a cloud-based information service and precision thermal shipping products based on SAVSU Technologies, LLC's (SAVSU's) next generation EVO smart container shipment platform.
HypoThermosol FRS
HypoThermosol biopreservation media is an engineered, optimized hypothermic storage and shipping media product. This optimized formulation mitigates temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products and final cell products intended for research and clinical applications. Serum-free, protein-free HypoThermosol FRS is designed to provide maximum storage and shipping stability for biologics at 2-8 degree Celsius.
CryoStor
CryoStor cryopreservation freeze media products mitigate temperature-induced molecular cell stress responses during freezing and thawing. CryoStor freeze media products are intended for cryopreservation of biologics at subzero temperatures (most often utilized within the range of -80 to -196 degree Celsius). All CryoStor products are pre-formulated with dimethyl sulfoxide (DMSO), a permeating cryoprotective agent, which helps mitigate damage from the formation of intracellular ice. CryoStor is offered in several packages and pre-formulated with DMSO in final concentrations of approximately 2%, 5% and 10%.
BloodStor
BloodStor freeze media is a series of generic freeze media products used to cryopreserve stem and other cells isolated from umbilical cord blood, peripheral blood and bone marrow where the processing methods require addition of high concentration DMSO. BloodStor 55-5 is pre-formulated with 55% weight/volume (w/v) DMSO USP/EP, approximately 5% (w/v) Dextran-40 the United States Pharmacopia/ European Pharmacopoeia (USP/EP) and Water for Injection (WFI) quality water. BloodStor 100 contains approximately 100% (w/v) DMSO USP/EP. BloodStor 27 NaCl is pre-formulated with approximately 27% (w/v) DMSO in saline components and Water for Injection (WFI) quality water.
Cell Thawing Media
Cell Thawing Media provides Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants. Cell thawing media is pre-formulated with approximately 10% Dextran 40 in over 0.9% NaCl and over 10% Dextran 40 in over 5% Dextrose.
PrepaStor
PrepaStor is a flush solution designed for use during the transitions from normothermic to mild hypothermic conditions to rinse culture media and native fluids from tissue and whole organ systems prior to suspension in a preservation solution. PrepaStor is also used to support the transition from hypothermic to normothermic temperatures following the preservation interval.
biologistex cold-chain management service
The Company's biologistex cold-chain management service includes unlimited use of the evo Smart Shipper and the integrated track and trace cloud-based Web application, mybiologistex.com. The line of evo Smart Shippers are reusable and designed for the shipment of materials, which must be maintained at precision temperature ranges, including frozen at -80 degree Celsius, chilled at 2 to 8 degree Celsius and at controlled room temperature (CRT) temperatures. The evo Smart Shippers include a traceable thermocouple embedded within the payload cavity to monitor the environmental conditions within the payload and a fiber optic sensor enabling monitoring whether the container is opened at any time during shipment and upon arrival at the destination. The monitoring data and Global Positioning System (GPS) location is transmitted in real time to its cloud based-Web application.
The Company competes with VWR, Sigma-Aldrich, Lonza, Life Technologies, STEMCELL Technologies, Sonoco Thermosafe, Cryopak and Pelican Technologies.
3303 Monte Villa Pkwy Ste 310
The company trades on NASDAQ exchange. The company headquarter is located in Washington, WA. The company was established in the 1987.| Ticker | BLFS |
| Long Name | BioLife Solutions, Inc. |
| Short Name | BioLife |